| Old Articles: <Older 37641-37650 Newer> |
|---|
 |
The Motley Fool
August 5, 2009
Toby Shute |
Ultra Petroleum's Ultra-Strong Results Wow. Just wow. In addition to rock-bottom costs, Ultra has delivered some of the most explosive debt-adjusted, per-share production growth of any of its peers.   |
The Motley Fool
August 5, 2009
Rick Aristotle Munarriz |
Google Is On2 Something Google snaps up video-compression specialist On2 Technologies, which will be put to good use alongside the growing collection of YouTube servers. |
The Motley Fool
August 5, 2009
Mike Pienciak |
Why These Companies Beat Kraft Improving profit and volume trends still don't make Kraft the food sector's best buy. |
The Motley Fool
August 5, 2009
Christopher Barker |
The Incredible Irony of Paltry Gold Profits Despite Yamana's stellar earnings numbers, toxic derivatives still lurk. |
The Motley Fool
August 5, 2009 |
3 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Actuate Corp... Capstead Mortgage Corp... Builders FirstSource, Inc. ... |
The Motley Fool
August 5, 2009
Brian Orelli |
The Cash Cow Is Out of Milk ViroPharma has milked its antibiotic Vancocin, which it bought from Eli Lilly in 2004, pretty well, but it looks like the cash cow is finally running dry. |
The Motley Fool
August 5, 2009
Rick Aristotle Munarriz |
A Tale of 2 Leisure Stocks Cedar Fair and Great Wolf Resorts went in different directions after posting their quarterly results. Let's look deeper at why. |
The Motley Fool
August 5, 2009
Rick Aristotle Munarriz |
4 Questions for Sirius XM Sirius XM Radio reports tomorrow. Here are four things to look for in the report. |
The Motley Fool
August 5, 2009
Brian Orelli |
Potential Can't Buy Me Love It's sad when investors can't get excited about a company doubling its earnings per share and posting 19% growth in sales of its drug, but Onyx isn't going to get any love until it gets some positive clinical trial data. |
The Motley Fool
August 5, 2009
Dan Caplinger |
These 5 Stocks Could Keep the Rally Going The rally isn't just about speculation anymore. Colgate-Palmolive, Merck, Coca Cola, Texas Instruments, and Analog Devices may be the ones that lead out of the recession. |
| <Older 37641-37650 Newer> Return to current articles. |
